January 2026
Default mode network
What January 2026's 6 new studies found, synthesized from the papers below. All Default mode network research →
The synthesis
Synthesized from 6 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for Default mode network, DMN, resting-state network, then ranked by relevance.
Research in January 2026 consistently identifies the default mode network (DMN) as a key neural substrate in psychedelic therapy, hypnosis, and psychiatric disorders, with findings showing that psychedelics like psilocybin reduce DMN activity and rigidity, correlating with therapeutic benefits. However, the evidence is largely from reviews and theoretical frameworks rather than new empirical studies, and one study on multiple sclerosis suggests DMN disruption may also occur in non-psychedelic contexts, indicating the DMN's role is complex and not fully understood.
Evidence by study
Direction is which way each study's own result points, not our rating of the study.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| Hypnosis as a Mechanism of Emotion Regulation and Self-Integration: Neural, Cognitive, and Experiential Pathways to Fundamental Peace 2026 | review | Supports | Hypnosis modulates the default mode network (DMN) along with other networks to reorganize emotional experience and self-referential processing. | |
| The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence 2026 | review | Supports | Psilocybin reduces DMN activity and connectivity, contributing to rapid and sustained antidepressant effects. | |
| THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026 | systematic review | Supports | Psilocybin and LSD cause disintegration of the DMN, which correlates with alleviation of rigid cognitive patterns in depression and anxiety. | |
| Altered excitation-inhibition balance in the somatomotor and default mode network in multiple sclerosis 2026 | observational | Unclear | Altered excitation-inhibition balance is observed in the DMN in multiple sclerosis, but the direction of effect on DMN function is not specified. | |
| The Experiential Self State as Affective Salience: Neurobiological, embodied, and predictive foundations of non-reflective consciousness 2026 | theoretical | Supports | The reflective self, underpinned by DMN activity, is contrasted with an experiential self state, and altered states like meditation can shift away from DMN-dominated processing. | |
| A Randomized Controlled Trial of Psilocybin for the Treatment of Obsessive-Compulsive Disorder 2026 | review | Supports | OCD is associated with a hyperfunctioning DMN, and psilocybin may break rigid neuronal patterns by modulating the DMN. |
Hypnosis modulates the default mode network (DMN) along with other networks to reorganize emotional experience and self-referential processing.
review
Psilocybin reduces DMN activity and connectivity, contributing to rapid and sustained antidepressant effects.
review
Psilocybin and LSD cause disintegration of the DMN, which correlates with alleviation of rigid cognitive patterns in depression and anxiety.
systematic review
Altered excitation-inhibition balance is observed in the DMN in multiple sclerosis, but the direction of effect on DMN function is not specified.
observational
The reflective self, underpinned by DMN activity, is contrasted with an experiential self state, and altered states like meditation can shift away from DMN-dominated processing.
theoretical
OCD is associated with a hyperfunctioning DMN, and psilocybin may break rigid neuronal patterns by modulating the DMN.
review
Points of agreement
- Psychedelics (psilocybin, LSD) reduce DMN activity and connectivity, which is linked to therapeutic effects in depression, anxiety, and OCD.
- Hypnosis and meditation also modulate the DMN, suggesting a common pathway for altering self-referential processing.
- DMN dysfunction is implicated in multiple psychiatric and neurological conditions, including OCD and multiple sclerosis.
Conflicts
- One study on multiple sclerosis reports altered DMN excitation-inhibition balance, but the direction (whether increased or decreased DMN activity) is unclear, contrasting with the consistent reduction seen in psychedelic studies.
- The theoretical framework in one study distinguishes between reflective (DMN-based) and experiential self states, but other studies do not explicitly adopt this dual-self model.
Gaps
- No new empirical neuroimaging data from January 2026 are provided; all studies are reviews or theoretical.
- The durability of DMN changes beyond the acute psychedelic experience is not addressed in the provided abstracts.
- Sample sizes and specific populations are not reported for most studies, limiting generalizability.
- The relationship between DMN modulation and clinical outcomes is correlational, not causal, in the reviewed evidence.